Highlights
AMEX: MTNB       Matinas Biopharma Hl
Last Price Today's Change   Day's Range   Trading Volume
1.64   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):3,988,893
4 Weeks Range:0.88 - 2.18
4 Weeks Price Volatility (%):
75.23%
52 Weeks Range:0.50 - 2.18
52 Weeks Price Volatility (%):
75.23%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Matinas BioPharma Holdings Inc is a US-based clinical-stage biopharmaceutical company which focuses on developing anti-infectives for orphan indications. The company's lead product candidate MAT2203 is an orally-administered cochleate formulation of a broad spectrum anti-fungal drug called amphotericin B and other clinical stage product candidate is MAT2501 which is a an orally administered, encochleated formulation of the broad spectrum aminoglycoside antibiotic amikacin which treats different types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections as well as various multidrug-resistant gram negative and intracellular bacterial infections.

  Be the first to like this.
 


 

3634  2095  324  2918 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.35+1.68 
 CHK 0.791+0.046 
 BAC 34.68+1.04 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers